Elevated Heme Synthesis and Uptake Underpin Intensified Oxidative Metabolism and Tumorigenic Functions in Non-Small Cell Lung Cancer Cells
- PMID: 30902795
- DOI: 10.1158/0008-5472.CAN-18-2156
Elevated Heme Synthesis and Uptake Underpin Intensified Oxidative Metabolism and Tumorigenic Functions in Non-Small Cell Lung Cancer Cells
Abstract
Tumors of human non-small cell lung cancer (NSCLC) are heterogeneous but exhibit elevated glycolysis and glucose oxidation relative to benign lung tissues. Heme is a central molecule for oxidative metabolism and ATP generation via mitochondrial oxidative phosphorylation (OXPHOS). Here, we showed that levels of heme synthesis and uptake, mitochondrial heme, oxygen-utilizing hemoproteins, oxygen consumption, ATP generation, and key mitochondrial biogenesis regulators were enhanced in NSCLC cells relative to nontumorigenic cells. Likewise, proteins and enzymes relating to heme and mitochondrial functions were upregulated in human NSCLC tissues relative to normal tissues. Engineered heme-sequestering peptides (HSP) reduced heme uptake, intracellular heme levels, and tumorigenic functions of NSCLC cells. Addition of heme largely reversed the effect of HSPs on tumorigenic functions. Furthermore, HSP2 significantly suppressed the growth of human NSCLC xenograft tumors in mice. HSP2-treated tumors exhibited reduced oxygen consumption rates (OCR) and ATP levels. To further verify the importance of heme in promoting tumorigenicity, we generated NSCLC cell lines with increased heme synthesis or uptake by overexpressing either the rate-limiting heme synthesis enzyme ALAS1 or uptake protein SLC48A1, respectively. These cells exhibited enhanced migration and invasion and accelerated tumor growth in mice. Notably, tumors formed by cells with increased heme synthesis or uptake also displayed elevated OCRs and ATP levels. These data show that elevated heme flux and function underlie enhanced OXPHOS and tumorigenicity of NSCLC cells. Targeting heme flux and function offers a potential strategy for developing therapies for lung cancer. SIGNIFICANCE: These findings show that elevated heme availability due to increased heme synthesis and uptake causes intensified oxygen consumption and ATP generation, promoting tumorigenic functions and tumor growth in NSCLC. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/79/10/2511/F1.large.jpg.
©2019 American Association for Cancer Research.
Similar articles
-
Cyclopamine tartrate, a modulator of hedgehog signaling and mitochondrial respiration, effectively arrests lung tumor growth and progression.Sci Rep. 2019 Feb 5;9(1):1405. doi: 10.1038/s41598-018-38345-1. Sci Rep. 2019. PMID: 30723259 Free PMC article.
-
Enhanced heme function and mitochondrial respiration promote the progression of lung cancer cells.PLoS One. 2013 May 21;8(5):e63402. doi: 10.1371/journal.pone.0063402. Print 2013. PLoS One. 2013. PMID: 23704904 Free PMC article.
-
Heme Sequestration Effectively Suppresses the Development and Progression of Both Lung Adenocarcinoma and Squamous Cell Carcinoma.Mol Cancer Res. 2022 Jan;20(1):139-149. doi: 10.1158/1541-7786.MCR-21-0385. Epub 2021 Oct 11. Mol Cancer Res. 2022. PMID: 34635508
-
Mitochondria Targeting as an Effective Strategy for Cancer Therapy.Int J Mol Sci. 2020 May 9;21(9):3363. doi: 10.3390/ijms21093363. Int J Mol Sci. 2020. PMID: 32397535 Free PMC article. Review.
-
Oncogenic Ect2 signaling regulates rRNA synthesis in NSCLC.Small GTPases. 2019 Sep;10(5):388-394. doi: 10.1080/21541248.2017.1335274. Epub 2017 Jul 5. Small GTPases. 2019. PMID: 28657426 Free PMC article. Review.
Cited by
-
Mitochondrial Heme Synthesis Enzymes as Therapeutic Targets in Vascular Diseases.Front Pharmacol. 2020 Jul 15;11:1015. doi: 10.3389/fphar.2020.01015. eCollection 2020. Front Pharmacol. 2020. PMID: 32760270 Free PMC article. No abstract available.
-
Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC.Int J Biol Sci. 2022 Oct 24;18(16):6163-6175. doi: 10.7150/ijbs.78354. eCollection 2022. Int J Biol Sci. 2022. PMID: 36439873 Free PMC article.
-
Heme Metabolism-Related Gene TENT5C is a Prognostic Marker and Investigating Its Immunological Role in Colon Cancer.Pharmgenomics Pers Med. 2023 Dec 23;16:1127-1143. doi: 10.2147/PGPM.S433790. eCollection 2023. Pharmgenomics Pers Med. 2023. PMID: 38152411 Free PMC article.
-
Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression.PLoS Genet. 2019 Oct 7;15(10):e1008439. doi: 10.1371/journal.pgen.1008439. eCollection 2019 Oct. PLoS Genet. 2019. PMID: 31589613 Free PMC article.
-
Metabolic Functions of Biliverdin IXβ Reductase in Redox-Regulated Hematopoietic Cell Fate.Antioxidants (Basel). 2023 May 7;12(5):1058. doi: 10.3390/antiox12051058. Antioxidants (Basel). 2023. PMID: 37237924 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials